Home/Filings/4/0000898432-19-001295
4//SEC Filing

Nardi Steven M. 4

Accession 0000898432-19-001295

CIK 0001325618other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 5:36 PM ET

Size

8.3 KB

Accession

0000898432-19-001295

Insider Transaction Report

Form 4
Period: 2019-11-04
Nardi Steven M.
VP of Manufacturing
Transactions
  • Sale

    Common Stock

    2019-11-04$24.36/sh1,250$30,4500 total
  • Award

    Common Stock

    2019-11-04$9.84/sh+1,250$12,3001,250 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-11-041,2500 total
    Exercise: $9.84Exp: 2024-12-15Common Stock (1,250 underlying)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $24.32 to $24.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This option, representing a right to purchase a total of 5,000 shares, was granted on 12/15/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

Documents

1 file

Issuer

IRADIMED CORP

CIK 0001325618

Entity typeother

Related Parties

1
  • filerCIK 0001613663

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 5:36 PM ET
Size
8.3 KB